hfdp cells Search Results


95
PromoCell human follicle dermal papilla cells
Human Follicle Dermal Papilla Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human follicle dermal papilla cells/product/PromoCell
Average 95 stars, based on 1 article reviews
human follicle dermal papilla cells - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
ScienCell hfdp cells
In vitro assessment of the effect of different concentrations of porphyra extract and porphyra-334 on cell viability and collagen synthesis. The effect of three different concentrations (1, 5, and 10 ppm) of porphyra extract and porphyra-334 on the cell viability of Detroit 551 cells was examined by MTT assay (a). C indicates control cells treated with distilled water. (b) PIP content was measured in Detroit 551 cells after treatment with different concentrations of porphyra extract and porphyra-334. TGF- β 1, which is known to promote collagen formation, cell proliferation, and the differentiation of dermal fibroblasts, was used as a positive control. (c) PIP content was measured in <t>HFDP</t> <t>cells</t> after treatment with different concentrations of porphyra-334. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗∗ p < 0.01.
Hfdp Cells, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hfdp cells/product/ScienCell
Average 90 stars, based on 1 article reviews
hfdp cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
TheraCyte Inc hfdp cell activity
In vitro assessment of the effect of different concentrations of porphyra extract and porphyra-334 on cell viability and collagen synthesis. The effect of three different concentrations (1, 5, and 10 ppm) of porphyra extract and porphyra-334 on the cell viability of Detroit 551 cells was examined by MTT assay (a). C indicates control cells treated with distilled water. (b) PIP content was measured in Detroit 551 cells after treatment with different concentrations of porphyra extract and porphyra-334. TGF- β 1, which is known to promote collagen formation, cell proliferation, and the differentiation of dermal fibroblasts, was used as a positive control. (c) PIP content was measured in <t>HFDP</t> <t>cells</t> after treatment with different concentrations of porphyra-334. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗∗ p < 0.01.
Hfdp Cell Activity, supplied by TheraCyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hfdp cell activity/product/TheraCyte Inc
Average 90 stars, based on 1 article reviews
hfdp cell activity - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
TheraCyte Inc human hair follicle dermal papilla (hfdp) cell groups
In vitro assessment of the effect of different concentrations of porphyra extract and porphyra-334 on cell viability and collagen synthesis. The effect of three different concentrations (1, 5, and 10 ppm) of porphyra extract and porphyra-334 on the cell viability of Detroit 551 cells was examined by MTT assay (a). C indicates control cells treated with distilled water. (b) PIP content was measured in Detroit 551 cells after treatment with different concentrations of porphyra extract and porphyra-334. TGF- β 1, which is known to promote collagen formation, cell proliferation, and the differentiation of dermal fibroblasts, was used as a positive control. (c) PIP content was measured in <t>HFDP</t> <t>cells</t> after treatment with different concentrations of porphyra-334. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗∗ p < 0.01.
Human Hair Follicle Dermal Papilla (Hfdp) Cell Groups, supplied by TheraCyte Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human hair follicle dermal papilla (hfdp) cell groups/product/TheraCyte Inc
Average 90 stars, based on 1 article reviews
human hair follicle dermal papilla (hfdp) cell groups - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


In vitro assessment of the effect of different concentrations of porphyra extract and porphyra-334 on cell viability and collagen synthesis. The effect of three different concentrations (1, 5, and 10 ppm) of porphyra extract and porphyra-334 on the cell viability of Detroit 551 cells was examined by MTT assay (a). C indicates control cells treated with distilled water. (b) PIP content was measured in Detroit 551 cells after treatment with different concentrations of porphyra extract and porphyra-334. TGF- β 1, which is known to promote collagen formation, cell proliferation, and the differentiation of dermal fibroblasts, was used as a positive control. (c) PIP content was measured in HFDP cells after treatment with different concentrations of porphyra-334. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗∗ p < 0.01.

Journal: Evidence-based Complementary and Alternative Medicine : eCAM

Article Title: Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq

doi: 10.1155/2021/6637513

Figure Lengend Snippet: In vitro assessment of the effect of different concentrations of porphyra extract and porphyra-334 on cell viability and collagen synthesis. The effect of three different concentrations (1, 5, and 10 ppm) of porphyra extract and porphyra-334 on the cell viability of Detroit 551 cells was examined by MTT assay (a). C indicates control cells treated with distilled water. (b) PIP content was measured in Detroit 551 cells after treatment with different concentrations of porphyra extract and porphyra-334. TGF- β 1, which is known to promote collagen formation, cell proliferation, and the differentiation of dermal fibroblasts, was used as a positive control. (c) PIP content was measured in HFDP cells after treatment with different concentrations of porphyra-334. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗∗ p < 0.01.

Article Snippet: Three different types of human cells were used in this study: human Detroit 551 fibroblast cells (ATCC, Manassas, VA, USA), human immortalized keratinocyte (HaCaT) cells (ATCC), and HFDP cells derived from mainly normal human scalp hair follicles (ScienCell, San Diego, CA, USA).

Techniques: In Vitro, MTT Assay, Control, Positive Control

In vitro assessment of the effect of different concentrations of porphyra-334 on cell viability in HaCaT and HFDP cells. The effect of six different concentrations (1, 5, 10, 50, 100, and 200 ppm) of porphyra-334 on cell viability was examined in HaCaT (a) and HFDP (b) cells by MTT assay. Control (c) indicates cells treated with distilled water. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.

Journal: Evidence-based Complementary and Alternative Medicine : eCAM

Article Title: Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq

doi: 10.1155/2021/6637513

Figure Lengend Snippet: In vitro assessment of the effect of different concentrations of porphyra-334 on cell viability in HaCaT and HFDP cells. The effect of six different concentrations (1, 5, 10, 50, 100, and 200 ppm) of porphyra-334 on cell viability was examined in HaCaT (a) and HFDP (b) cells by MTT assay. Control (c) indicates cells treated with distilled water. For the comparisons between the positive sample (TGF- β 1) and the treatment group, we conducted independent t -tests. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.

Article Snippet: Three different types of human cells were used in this study: human Detroit 551 fibroblast cells (ATCC, Manassas, VA, USA), human immortalized keratinocyte (HaCaT) cells (ATCC), and HFDP cells derived from mainly normal human scalp hair follicles (ScienCell, San Diego, CA, USA).

Techniques: In Vitro, MTT Assay, Control

Twenty-seven identified genes (39 transcripts) in  HFDP cells  upregulated by porphyra-344 treatment.

Journal: Evidence-based Complementary and Alternative Medicine : eCAM

Article Title: Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq

doi: 10.1155/2021/6637513

Figure Lengend Snippet: Twenty-seven identified genes (39 transcripts) in HFDP cells upregulated by porphyra-344 treatment.

Article Snippet: Three different types of human cells were used in this study: human Detroit 551 fibroblast cells (ATCC, Manassas, VA, USA), human immortalized keratinocyte (HaCaT) cells (ATCC), and HFDP cells derived from mainly normal human scalp hair follicles (ScienCell, San Diego, CA, USA).

Techniques: Variant Assay, Ubiquitin Proteomics

Sixteen identified genes (43 transcripts) in  HFDP cells  downregulated by porphyra-334 treatment.

Journal: Evidence-based Complementary and Alternative Medicine : eCAM

Article Title: Transcriptome Profiling of Human Follicle Dermal Papilla Cells in response to Porphyra-334 Treatment by RNA-Seq

doi: 10.1155/2021/6637513

Figure Lengend Snippet: Sixteen identified genes (43 transcripts) in HFDP cells downregulated by porphyra-334 treatment.

Article Snippet: Three different types of human cells were used in this study: human Detroit 551 fibroblast cells (ATCC, Manassas, VA, USA), human immortalized keratinocyte (HaCaT) cells (ATCC), and HFDP cells derived from mainly normal human scalp hair follicles (ScienCell, San Diego, CA, USA).

Techniques: Binding Assay, Ubiquitin Proteomics